ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:06 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 52
Drug details and screening numbers
Drug Name: GNF-2
Drug ID: 52
Synonyms: KIN001-013 (GNF-2 / 3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide)
Brand name:
Target: ABL [T315I]
Number of cell lines screened: 399
Screening concentration range(s): 0.005 to 1.28 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a8 |
BCR-ABL_mut |
52 |
1 |
1 |
GNF-2 |
ABL [T315I] |
5 |
393 |
0.247 |
2.4 |
-0.761 |
-3.16 |
4 ** |
4.2 ** |
1.7 * |
1.24e-14 |
6.43e-06 |
8.71e-01 |
2.6e-08 |
All-tests volcano plot